Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
UNIVERSITA DEGLI STUDI DE GENOVA has 1 pending office action in Biotechnology & Pharmaceuticals. The record identifies 1 distinct examiner and 1 distinct art unit, indicating a concentrated examination path.
DAHLIN, HEATHER RAQUEL is the busiest examiner, with 1 pending matter. Practitioners can focus technical submissions and claim strategy on one biotechnology record and one examiner relationship.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DAHLIN, HEATHER RAQUEL | 1 | 42.2% | +47.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18022088 | THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER | DAHLIN, HEATHER RAQUEL | — |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18022088 | THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER | DAHLIN, HEATHER RAQUEL | 1629 | §103Other | Final Rejection | — | Pending | Feb 17, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITA DEGLI STUDI DE GENOVA has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Heather Raquel Dahlin has the most, with 1 of UNIVERSITA DEGLI STUDI DE GENOVA's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
